Literature DB >> 1541377

Clinical observations and experiments in diabetic neuropathy.

P J Watkins1.   

Abstract

Diabetic neuropathies form a group of diverse conditions, which can be distinguished between those which recover (acute painful neuropathies, radiculopathies, mononeuropathies) and those which progress (sensory and autonomic neuropathies). These two main groups can be distinguished in several ways: sensory and autonomic neuropathies are classic diabetic complications progressing gradually in patients with long-standing diabetes who often have other specific complications, while the reversible neuropathies do not have these features. The latter are characterised by their occurrence at any stage of diabetes, often at diagnosis, they may be precipitated on starting insulin treatment, and they are more common in men; they can occur at any age, though more often in older patients, and are unrelated to other diabetic complications. The two groups of neuropathies also show differences in nerve structural abnormalities and with regard to distinctive blood flow responses. The underlying mechanisms responsible for these very different forms of neuropathy remain speculative, but evidence for an immunological basis for the development of severe symptomatic autonomic neuropathy is presented.

Entities:  

Mesh:

Year:  1992        PMID: 1541377     DOI: 10.1007/bf00400845

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  53 in total

1.  The syndrome of diabetic amyotrophy.

Authors:  S Chokroverty; M G Reyes; F A Rubino; H Tonaki
Journal:  Ann Neurol       Date:  1977-09       Impact factor: 10.422

2.  Failure of improved glycaemic control to reverse diabetic autonomic neuropathy. The St Thomas's Diabetic Study Group.

Authors: 
Journal:  Diabet Med       Date:  1986 Jul-Aug       Impact factor: 4.359

3.  Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study.

Authors:  G Solders; H Wilczek; R Gunnarsson; G Tydén; A Persson; C G Groth
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

4.  Cardiorespiratory arrest and diabetic autonomic neuropathy.

Authors:  M M Page; P J Watkins
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

5.  Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients.

Authors:  J A Bastron; J E Thomas
Journal:  Mayo Clin Proc       Date:  1981-12       Impact factor: 7.616

6.  Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics.

Authors:  M J Sampson; S Wilson; P Karagiannis; M Edmonds; P J Watkins
Journal:  Q J Med       Date:  1990-06

7.  Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications.

Authors:  J M Steel; R J Young; G G Lloyd; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-04

8.  The natural history of painful diabetic neuropathy--a 4-year study.

Authors:  A J Boulton; W D Armstrong; J H Scarpello; J D Ward
Journal:  Postgrad Med J       Date:  1983-09       Impact factor: 2.401

9.  Uveitis and diabetes mellitus.

Authors:  A Rothova; C Meenken; R P Michels; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1988-07-15       Impact factor: 5.258

10.  Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.

Authors:  S L Rabinowe; F M Brown; M Watts; M M Kadrofske; A I Vinik
Journal:  Diabetes Care       Date:  1989-01       Impact factor: 19.112

View more
  9 in total

1.  Case report: patient's perspective on acute diabetic neuropathy.

Authors:  C S Kargel; M Godwin; D Alexander
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

2.  Oxidative stress and autonomic nerve function in early type 1 diabetes.

Authors:  Robert Daniel Hoeldtke; Kimberly D Bryner; Knox VanDyke
Journal:  Clin Auton Res       Date:  2010-09-25       Impact factor: 4.435

3.  Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.

Authors:  G D Valk; A C Kappelle; A M Tjon-A-Tsien; B Bravenboer; K Bakker; R P Michels; C M Groenhout; F W Bertelsmann
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

4.  C-peptide improves autonomic nerve function in IDDM patients.

Authors:  B L Johansson; K Borg; E Fernqvist-Forbes; T Odergren; S Remahl; J Wahren
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

5.  Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor.

Authors:  T J Faes; G A Yff; O DeWeerdt; P Lanting; J J Heimans; F W Bertelsmann
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

6.  Prevalence and forms of neuropathic morbidity in 800 diabetics.

Authors:  J A O'Hare; F Abuaisha; M Geoghegan
Journal:  Ir J Med Sci       Date:  1994-03       Impact factor: 1.568

Review 7.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

8.  Restoring lower limb blood flow improves conduction velocity in diabetic patients.

Authors:  M J Young; A Veves; J V Smith; M G Walker; A J Boulton
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

Review 9.  Autonomic disturbances in diabetes: Assessment and anaesthetic implications.

Authors:  Srilata Moningi; Sapna Nikhar; Gopinath Ramachandran
Journal:  Indian J Anaesth       Date:  2018-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.